X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216904
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-14-2022-47942.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-7-2022-68481.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216922
https://www.pharmatimes.com/news/alturix_acquires_uk_rights_to_desmopressin_oral_solution_1456346
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215961
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-6-2022-1657105109.pdf
https://www.fiercepharma.com/manufacturing/tevas-halt-production-troubled-plant-seen-create-shortages-range-injectables
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210223
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ferring-us-issues-voluntary-nationwide-recall-ddavpr-nasal-spray-10-mcg01ml-desmopressin-acetate
https://www.moneycontrol.com/news/business/dr-reddys-laboratories-launches-generic-hemophilia-injection-in-us-5230401.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-26-2020-1582696769.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210218
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-12-2020-1581485052.pdf
https://www.fiercepharma.com/pharma/roche-merck-novartis-and-others-raise-prices-83-meds-to-start-july-analyst?utm_source=internal&utm_medium=rss
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210371
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091345
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204695
https://www.pharmacompass.com/pdf/news/noctiva-desmopressin-ferring-pharmaceuticals-v-serenity-pharmaceuticals-reprise-biopharmaceutics-allergan-inc-1494843384.pdf
http://www.prnewswire.com/news-releases/fda-approves-first-treatment-for-frequent-urination-at-night-due-to-overproduction-of-urine-300417877.html
http://www.pharmatimes.com/news/ferring_launches_nocturia_drug_for_adults_of_all_ages_1175215
http://www.prnewswire.com/news-releases/fda-advisory-committee-recommends-approval-of-ser120-desmopressin-nasal-spray-300348687.html
http://www.reuters.com/article/us-allergan-fda-urology-idUSKBN12H1IJ
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30
http://www.ferring.com/en/media/press-releases/2015/ctcbio-drug-acquisition-23-feb-15/
Market Place
Share 
